Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
61,078,573
-
Share change
-
+2,992,903
-
Total reported value
-
$6,058,905,131
-
Put/Call ratio
-
53%
-
Price per share
-
$99.20
-
Number of holders
-
242
-
Value change
-
+$247,459,592
-
Number of buys
-
127
-
Number of sells
-
150
Institutional Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q4 2018
As of 31 Dec 2018,
BLUEBIRD BIO INC - COM (BLUE) was held by
242 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,078,573 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, Capital International Investors, Vanguard Group Inc, BAILLIE GIFFORD & CO, Capital World Investors, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, and STATE STREET CORP.
This page lists
242
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.